BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 19896096)

  • 21. Hypothetical progression model of pancreatic cancer with origin in the centroacinar-acinar compartment.
    Esposito I; Seiler C; Bergmann F; Kleeff J; Friess H; Schirmacher P
    Pancreas; 2007 Oct; 35(3):212-7. PubMed ID: 17895840
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Class III beta-tubulin, a marker of resistance to paclitaxel, is overexpressed in pancreatic ductal adenocarcinoma and intraepithelial neoplasia.
    Lee KM; Cao D; Itami A; Pour PM; Hruban RH; Maitra A; Ouellette MM
    Histopathology; 2007 Oct; 51(4):539-46. PubMed ID: 17714470
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preinvasive pancreatic neoplasia of ductal phenotype induced by acinar cell targeting of mutant Kras in transgenic mice.
    Grippo PJ; Nowlin PS; Demeure MJ; Longnecker DS; Sandgren EP
    Cancer Res; 2003 May; 63(9):2016-9. PubMed ID: 12727811
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Intraepithelial neoplasm of the pancreas].
    Zalatnai A
    Orv Hetil; 2004 Jan; 145(1):19-23. PubMed ID: 15222136
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pancreatic cancer: a plea for good and comprehensive morphological studies.
    Algül H; Schmid RM
    Eur J Gastroenterol Hepatol; 2008 Aug; 20(8):713-5. PubMed ID: 18617774
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Where and when does pancreatic carcinoma start?
    Lüttges J; Hahn S; Klöppel G
    Med Klin (Munich); 2004 Apr; 99(4):191-5. PubMed ID: 15085289
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ductal pancreatic cancer in humans and mice.
    Tuveson DA; Hingorani SR
    Cold Spring Harb Symp Quant Biol; 2005; 70():65-72. PubMed ID: 16869739
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exclusion of SMAD4 mutation as an early genetic change in human pancreatic ductal tumorigenesis.
    Inoue H; Furukawa T; Sunamura M; Takeda K; Matsuno S; Horii A
    Genes Chromosomes Cancer; 2001 Jul; 31(3):295-9. PubMed ID: 11391801
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Current understanding of precursors to pancreatic cancer.
    Takaori K
    J Hepatobiliary Pancreat Surg; 2007; 14(3):217-23. PubMed ID: 17520195
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Biological aspects of pancreatic cancer].
    Tonel E; Carbone A; Scirelli T; Bellone G; Emanuelli G
    Minerva Med; 2005 Apr; 96(2):87-94. PubMed ID: 16172578
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanisms of disease: chronic inflammation and cancer in the pancreas--a potential role for pancreatic stellate cells?
    Algül H; Treiber M; Lesina M; Schmid RM
    Nat Clin Pract Gastroenterol Hepatol; 2007 Aug; 4(8):454-62. PubMed ID: 17667994
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Histopathologic evaluation of stepwise progression of pancreatic carcinoma with immunohistochemical analysis of gastric epithelial transcription factor SOX2: comparison of expression patterns between invasive components and cancerous or nonneoplastic intraductal components.
    Sanada Y; Yoshida K; Ohara M; Oeda M; Konishi K; Tsutani Y
    Pancreas; 2006 Mar; 32(2):164-70. PubMed ID: 16552336
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular genetics of pancreatic neoplasms and their morphologic correlates: an update on recent advances and potential diagnostic applications.
    Reid MD; Saka B; Balci S; Goldblum AS; Adsay NV
    Am J Clin Pathol; 2014 Feb; 141(2):168-80. PubMed ID: 24436263
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetics of Pancreatic Cancer and Its Implications on Therapy.
    Tatarian T; Winter JM
    Surg Clin North Am; 2016 Dec; 96(6):1207-1221. PubMed ID: 27865273
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A Novel Treatment Strategy for Pancreatic Cancer Based on Gene Profiles].
    Hayashi H; Nishihara H
    Gan To Kagaku Ryoho; 2016 Nov; 43(11):1326-1331. PubMed ID: 27899773
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular Alterations in Pancreatic Cancer: Transfer to the Clinic.
    Rodríguez Gil Y; Jiménez Sánchez P; Muñoz Velasco R; García García A; Sánchez-Arévalo Lobo VJ
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33669845
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pancreatic cancer.
    Maitra A; Hruban RH
    Annu Rev Pathol; 2008; 3():157-88. PubMed ID: 18039136
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Experimental animal models of pancreatic carcinogenesis and metastasis.
    Wei D; Xiong HQ; Abbruzzese JL; Xie K
    Int J Gastrointest Cancer; 2003; 33(1):43-60. PubMed ID: 12909737
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanistic analysis and chemoprevention of pancreatic carcinogenesis.
    Konishi Y; Tsutsumi M; Longnecker DS
    Pancreas; 1998 Nov; 17(4):334-40. PubMed ID: 9821174
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Refining targeted therapeutic approaches in pancreatic cancer: from histology and molecular pathology to the clinic.
    Mattiolo P; Kryklyva V; Brosens LA; Mafficini A; Lawlor RT; Milella M; Scarpa A; Corbo V; Luchini C
    Expert Opin Ther Targets; 2022 Jan; 26(1):1-4. PubMed ID: 34936525
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.